Riz , my understanding of the science may not be much

New Post Public Reply Private Reply Replies (1) Message Board
chazzledazzle Riztheinvestor #132560
584
Riz , my understanding of the science may not be much better, but our effect on other chemokibes may hold the answer. If indeed, we have use in MS it may be the anti-inflammatory and immune modulating effects LL has across the immune system - rebalancing the CD4/CD8 ratio, for instance.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156228/

“Although most research on the pathogenesis of MS has focused on the role of CD4 T cells, in fact, compared to most animal models, the main T cells found in the central nervous system of MS patients are CD8 T cells, suggesting that CD8 T Cells may play an important role in human disease [52]. There is growing evidence indicates that successful treatments are often related to changes in many other lymphocyte subpopulations, including B cells, NK cells, Lti cells, other ILC cells, γδT cells, NKT cells, MAIT cells and innate B cells. These findings not only indicate that multiple lymphocyte subpopulations are involved in the pathogenesis of the disease, but also identify the cells as potential targets for immunotherapy [117].”

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Rise of $1000 Investment in Chipotle Over 15 Years

Updated Category News Views 169

Understanding the Growth of Chipotle Mexican Grill Investing in the stock market can be a rewarding endeavor, especially when it comes to companies like Chipotle Mexican Grill (NYSE: CMG). Over the past 15 years, Chipotle has not only survived turbulent market conditions but has significantly outperformed them. This article takes a closer look at how an initial investment...

Continue Reading
Lockheed Martin Lands Major F-22 Upgrade Contract Worth $270M

Updated Category News Views 490

Lockheed Martin Secures Major Contract for F-22 Raptor Lockheed Martin (NYSE: LMT), a titan in the Aerospace & Defense sector, recently celebrated a significant achievement with the acquisition of a $270 million contract from the U.S. Air Force. This contract is aimed at upgrading the F-22 Raptor, equipping it with a next-generation Infrared Defensive System (IRDS). The...

Continue Reading
Understanding Market Trends and Sentiment Around UiPath

Updated Category News Views 194

Understanding Market Trends and Sentiment Around UiPath UiPath has recently seen a notable shift in its short percent of float, which has decreased by 25.0% since the company's last report. This change indicates a positive sentiment among traders as the number of shares sold short has reached 23.76 million, accounting for approximately 5.61% of all shares available for...

Continue Reading
Clene Inc. Prepares for Upcoming Growth Conference Presentation

Updated Category News Views 131

Clene Inc. Prepares for Upcoming Growth Conference Presentation Clene Inc. (Nasdaq: CLNN), a company at the forefront of biopharmaceutical innovation, is gearing up for its presentation at the Emerging Growth Conference. The event offers an excellent platform for Clene to showcase its commitment to advancing treatments for neurodegenerative diseases, particularly through...

Continue Reading
Insights Into CNX Resources' Upcoming Earnings Report

Updated Category News Views 107

Preparing for CNX Resources' Earnings Release CNX Resources (NASDAQ: CNX) is on the verge of announcing its quarterly earnings. These earnings reports are crucial events for investors, providing insights into the company's financial health and future prospects. As the earnings date approaches, investors are brimming with anticipation regarding how the figures will align...

Continue Reading